The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The folding-unfolding mechanism of the cytoplasmic region probably plays an important role for PLN interactions with other binding partners[41].”
From Effects of the Arg9Cys and Arg25Cys mutations on phospholamban's conformational equilibrium in membrane bilayers (2018) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535
Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., Borow, K., Dittrich, H., Zsebo, K. M., & Hajjar, R. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.013 · Cited by 457
del Monte, F., Williams, E., Lebeche, D., Schmidt, U., Rosenzweig, A., Gwathmey, J. K., Lewandowski, E. D., & Hajjar, R. J. (2001) · Circulation · doi:10.1161/hc3601.095574 · Cited by 382
Zsebo, K., Yaroshinsky, A., Rudy, J. J., Wagner, K., Greenberg, B., Jessup, M., & Hajjar, R. J. (2014) · Circulation Research · doi:10.1161/circresaha.113.302421 · Cited by 315
The enhanced contractility of the phospholamban-deficient mouse heart persists with aging
Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., Tamura, T., Tilgmann, C., James, P. F., Johnson, R., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1370 · Cited by 64
Self-citation
Research works printed but not linked: 69
- Kranias, 2012, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ Res, 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
- Steenaart, 1992, The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme, Arch Biochem Biophys, 293, 17, 10.1016/0003-9861(92)90359-5 · doi:10.1016/0003-9861(92)90359-5
- Carr, 2002, Type 1 phosphatase, a negative regulator of cardiac function, Mol Cell Biol, 22, 4124, 10.1128/MCB.22.12.4124-4135.2002 · DOI · Paper page
- Pathak, 2005, Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1, Circ Res, 96, 756, 10.1161/01.RES.0000161256.85833.fa · DOI · Paper page
- Zhao, 2009, The anti-apoptotic protein HAX-1 is a regulator of cardiac function, Proc Natl Acad Sci, 106, 20776, 10.1073/pnas.0906998106 · DOI · Paper page
- Arvanitis, 2007, Histidine-rich Ca2+-binding protein interacts with sarcoplasmic reticulum Ca2+-ATPase, Am J Physiol Heart Circ Physiol, 293, H1581, 10.1152/ajpheart.00278.2007 · DOI
- Park, 2013, Targeted ablation of the histidine-rich Ca2+-binding protein (HRC) gene is associated with abnormal SR Ca2+-cycling and severe pathology under pressure-overload stress, Basic Res Cardiol, 108, 344, 10.1007/s00395-013-0344-2 · doi:10.1007/s00395-013-0344-2
- Vafiadaki, 2013, Identification of a protein phosphatase 1/phospholamban interactome that is regulated by cAMP-dependent phosphorylation, PLoS ONE, 8, e80867, 10.1371/journal.pone.0080867 · DOI
- He, 1997, Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation, J Clin Invest, 100, 380, 10.1172/JCI119544 · DOI · Paper page
- Ji, 2000, Disruption of a single copy of the SERCA2 gene results in altered Ca2+ homeostasis and cardiomyocyte function, J Biol Chem, 275, 38073, 10.1074/jbc.M004804200 · DOI
- Anderson, 2009, Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene, J Mol Cell Cardiol, 47, 180, 10.1016/j.yjmcc.2009.03.013 · DOI
- Heinis, 2013, Prominent heart organ-level performance deficits in a genetic model of targeted severe and progressive SERCA2 deficiency, PLoS ONE, 8, e79609, 10.1371/journal.pone.0079609 · DOI
- Louch, 2010, Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout, J Physiol, 588, 465, 10.1113/jphysiol.2009.183517 · doi:10.1113/jphysiol.2009.183517
- Dash, 2001, Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium, J Mol Cell Cardiol, 33, 1345, 10.1006/jmcc.2001.1394 · DOI · Paper page
- Kawase, 2008, Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure, J Am Coll Cardiol, 51, 1112, 10.1016/j.jacc.2007.12.014 · DOI · Paper page
- Jessup, 2011, Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure, Circulation, 124, 304, 10.1161/CIRCULATIONAHA.111.022889 · DOI · Paper page
- Kho, 2011, SUMO1-dependent modulation of SERCA2a in heart failure, Nature, 477, 601, 10.1038/nature10407 · DOI · Paper page
- Tilemann, 2013, SUMO-1 gene transfer improves cardiac function in a large-animal model of heart failure, Sci Transl Med, 5, 211ra159, 10.1126/scitranslmed.3006487 · DOI
- MacLennan, 1998, Sites of regulatory interaction between calcium ATPases and phospholamban, Ann N Y Acad Sci, 853, 31, 10.1111/j.1749-6632.1998.tb08254.x · DOI · Paper page
- Chen, 2006, Cross-linking of C-terminal residues of phospholamban to the Ca2+ pump in cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain, J Biol Chem, 281, 14163, 10.1074/jbc.M601338200 · DOI · Paper page
- Chen, 2007, Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12, J Biol Chem, 282, 20968, 10.1074/jbc.M703516200 · DOI
- Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J Biol Chem, 283, 28996, 10.1074/jbc.M804782200 · DOI
- Pallikkuth, 2013, Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase, Biophys J, 105, 1812, 10.1016/j.bpj.2013.08.045 · DOI · Paper page
- Glaves, 2011, Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump, J Mol Biol, 405, 707, 10.1016/j.jmb.2010.11.014 · DOI · Paper page
- Kadambi, 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice, J Clin Invest, 97, 533, 10.1172/JCI118446 · DOI · Paper page
- Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation, Circ Res, 75, 401, 10.1161/01.RES.75.3.401 · DOI · Paper page
- Lorenz, 1997, Regulatory effects of phospholamban on cardiac function in intact mice, Am J Physiol, 273, H2826
- del Monte, 2002, Targeting phospholamban by gene transfer in human heart failure, Circulation, 105, 904, 10.1161/hc0802.105564 · DOI · Paper page
- Brittsan, 2000, Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban, J Biol Chem, 275, 12129, 10.1074/jbc.275.16.12129 · DOI
- Ziolo, 2005, Adenoviral gene transfer of mutant phospholamban rescues contractile dysfunction in failing rabbit myocytes with relatively preserved SERCA function, Circ Res, 96, 815, 10.1161/01.RES.0000163981.97262.3b · DOI
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J Clin Invest, 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc Natl Acad Sci U S A, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- Medeiros, 2011, Mutations in the human phospholamban gene in patients with heart failure, Am Heart J, 162, 1088, 10.1016/j.ahj.2011.07.028 · DOI
- van der Zwaag, 2012, Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy, Eur J Heart Fail, 14, 1199, 10.1093/eurjhf/hfs119 · DOI · Paper page
- Haghighi, 2012, The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase, J Mol Cell Cardiol, 52, 773, 10.1016/j.yjmcc.2011.11.012 · DOI · Paper page
- Minamisawa, 2003, Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy, Biochem Biophys Res Commun, 304, 1, 10.1016/S0006-291X(03)00526-6 · DOI
- Haghighi, 2008, A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids, Hum Mutat, 29, 640, 10.1002/humu.20692 · DOI
- Medin, 2007, Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN −42 C>G mutation, Eur J Heart Fail, 9, 37, 10.1016/j.ejheart.2006.04.007 · DOI
- Vafiadaki, 2007, Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function, J Mol Biol, 367, 65, 10.1016/j.jmb.2006.10.057 · DOI
- Chao, 2008, Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons, Nature, 452, 98, 10.1038/nature06604 · DOI · Paper page
- Lam, 2013, Novel role of HAX-1 in ischemic injury protection: involvement of Hsp90, Circ Res, 112, 79, 10.1161/CIRCRESAHA.112.279935 · DOI
- Neumann, 1997, Increased expression of cardiac phosphatases in patients with end-stage heart failure, J Mol Cell Cardiol, 29, 265, 10.1006/jmcc.1996.0271 · DOI · Paper page
- Huang, 1976, Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle, Eur J Biochem, 70, 419, 10.1111/j.1432-1033.1976.tb11032.x · DOI · Paper page
- Picking, 1991, Fluorescence studies on the interaction of inhibitor 2 and okadaic acid with the catalytic subunit of type 1 phosphoprotein phosphatases, Biochemistry, 30, 10280, 10.1021/bi00106a028 · DOI
- Sakashita, 2003, Regulation of type 1 protein phosphatase/inhibitor-2 complex by glycogen synthase kinase-3beta in intact cells, J Biochem, 133, 165, 10.1093/jb/mvg020 · DOI
- Kirchhefer, 2005, Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2, Cardiovasc Res, 68, 98, 10.1016/j.cardiores.2005.05.019 · DOI
- Yamada, 2006, Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy, FASEB J, 20, 1197, 10.1096/fj.05-5299fje · DOI
- El-Armouche, 2006, Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes, Biochem Biophys Res Commun, 346, 700, 10.1016/j.bbrc.2006.05.182 · DOI
- Rodriguez, 2007, Phosphorylation of human inhibitor-1 at Ser67 and/or Thr75 attenuates stimulatory effects of protein kinase A signaling in cardiac myocytes, Am J Physiol Heart Circ Physiol, 293, H762, 10.1152/ajpheart.00104.2007 · doi:10.1152/ajpheart.00104.2007
- Nicolaou, 2009, Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury, Circ Res, 104, 1012, 10.1161/CIRCRESAHA.108.189811 · DOI
- Pritchard, 2013, Active inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing hearts, PLoS ONE, 8, e80717, 10.1371/journal.pone.0080717 · DOI
- Fish, 2013, AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling, Circ Heart Fail, 6, 310, 10.1161/CIRCHEARTFAILURE.112.971325 · DOI
- Chen, 2008, A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to beta-adrenergic stimulation, FASEB J, 22, 1790, 10.1096/fj.07-097428 · DOI
- Chu, 2004, Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation: identification and characterization of a cardiac heat shock protein p20, Circ Res, 94, 184, 10.1161/01.RES.0000107198.90218.21 · doi:10.1161/01.res.0000107198.90218.21
- Fan, 2005, Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury, Circulation, 111, 1792, 10.1161/01.CIR.0000160851.41872.C6 · DOI · Paper page
- Dreiza, 2010, The small heat shock protein, HSPB6, in muscle function and disease, Cell Stress Chaperones, 15, 1, 10.1007/s12192-009-0127-8 · DOI
- Qian, 2011, Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling, Circ Res, 108, 1429, 10.1161/CIRCRESAHA.110.237644 · doi:10.1161/circresaha.110.237644
- Fan, 2005, Hsp20 and its cardioprotection, Trends Cardiovasc Med, 15, 138, 10.1016/j.tcm.2005.05.004 · DOI
- Qian, 2009, Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death, Circ Res, 105, 1223, 10.1161/CIRCRESAHA.109.200378 · DOI
- Nicolaou, 2008, Human mutation in the anti-apoptotic heat shock protein 20 abrogates its cardioprotective effects, J Biol Chem, 283, 33465, 10.1074/jbc.M802307200 · DOI
- Hofmann, 1989, Molecular cloning of a histidine-rich Ca2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements, J Biol Chem, 264, 18083, 10.1016/S0021-9258(19)84681-1 · DOI
- Sacchetto, 1999, Interaction of triadin with histidine-rich Ca2+-binding protein at the triadic junction in skeletal muscle fibers, J Muscle Res Cell Motil, 20, 403, 10.1023/A:1005580609414 · doi:10.1023/a:1005580609414
- Zhang, 1997, Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane, J Biol Chem, 272, 23389, 10.1074/jbc.272.37.23389 · DOI · Paper page
- Lee, 2001, Interaction of HRC (histidine-rich Ca2+-binding protein) and triadin in the lumen of sarcoplasmic reticulum, J Biol Chem, 276, 39533, 10.1074/jbc.M010664200 · doi:10.1074/jbc.m010664200
- Gyorke, 2004, The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium, Biophys J, 86, 2121, 10.1016/S0006-3495(04)74271-X · DOI · Paper page
- Gregory, 2006, Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function, J Mol Cell Cardiol, 40, 653, 10.1016/j.yjmcc.2006.02.003 · DOI
- Arvanitis, 2008, The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy, Eur Heart J, 29, 2514, 10.1093/eurheartj/ehn328 · DOI
- Singh, 2013, Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding protein, J Am Heart Assoc, 2, e000460, 10.1161/JAHA.113.000460 · doi:10.1161/jaha.113.000460
Cited by
Nelson, S. E. D., Ha, K. N., Gopinath, T., Exline, M. H., Mascioni, A., Thomas, D. D., & Veglia, G. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.030 · Cited by 16
Metadata
- Authors
- Haghighi, K., Bidwell, P., & Kranias, E. G.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 77
- Pages
- 160-167
- ISSN
- 0022-2828
- Cited by
- 101
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- NIH (HL-26057, HL-64018)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend. https://app.cochat.ai/papers/10.1016/j.yjmcc.2014.10.005
- The paper
- Haghighi, K., Bidwell, P., & Kranias, E. G. (2014). Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend. Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2014.10.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.